The low-dose steroid treatment dexamethasone is a major breakthrough in the fight against the deadly virus, UK experts say.
The drug is part of the world's biggest trial testing existing treatments to see if they also work for coronavirus.
It cut the risk of death by a third for patients on ventilators. For those on oxygen, it cut deaths by a fifth.
https://www.bbc.com/news/health-53061281
The anti-inflammatories can cut down on the cytokine storm that seems to be a substantial COVID risk.
Monocolonal antibodies have also had success in enabling the body to fight COVID.
https://www.nytimes.com/reuters/2020/06/16/world/asia/16reuters-health-coronavirus-singapore-vaccine.html
https://bgr.com/2020/06/15/coronavirus-treatment-monoclonal-antibody-cure-eli-lilly-vs-vaccine/
16 Jun 20
@sh76 saidSounds promising. I'm sure a vaccine or effective treatment will be found one day. I've never seen a virus this difficult to defeat.The low-dose steroid treatment dexamethasone is a major breakthrough in the fight against the deadly virus, UK experts say.
The drug is part of the world's biggest trial testing existing treatments to see if they also work for coronavirus.
It cut the risk of death by a third for patients on ventilators. For those on oxygen, it cut deaths by a fifth.
https:/ ...[text shortened]... l
https://bgr.com/2020/06/15/coronavirus-treatment-monoclonal-antibody-cure-eli-lilly-vs-vaccine/
16 Jun 20
For the just-in-case folder:
Hadassah researchers discovered that the patients who form these fatal clots have an increased level of alpha defensin protein in their blood, explained Dr. Abd Alrauf Higavi, who directs a lab at Hadassah and has been studying blood clots for 30 years.
“Patients with mild symptoms have a low concentration of alpha defensin,” he said. “Patients with strong disease symptoms have high levels. The people who die have very high levels.”
The Hadassah team studied more than 700 blood samples from 80 patients who were admitted to the medical center during the first peak of the coronavirus outbreak in Israel. The results show that alpha defensin speeds up blood clot formation, which can cause pulmonary embolism, heart attacks and stroke. In addition, when blood clots form in the alveoli, whose function it is to exchange oxygen and carbon dioxide molecules to and from the bloodstream, this can lead to respiratory distress and eventually intubation.
Multiple studies have shown that around 80% of coronavirus patients who are intubated have died.
Higavi said his team are en route to a solution: administering the drug colchicine to coronavirus patients.
Colchicine is an approved drug used in the prevention and treatment of gout attacks, caused by too much uric acid in the blood.
Higavi said they have completed testing colchicine on mice and found that it successfully inhibited the release of alpha defensin. Now, they are waiting for the necessary approvals to test it on human coronavirus patients.
The researcher said that clinical trials would look at use of the drug both for severe cases and administering it to patients with mild or moderate symptoms to see if it will help decrease the chances of their developing a severe case of the disease.
“The drugs available today in the blood-thinning market do not fully address this clotting, since its mechanism differs from the mechanisms for which these drugs currently exist,” Higavi said. “Resources should be diverted to finding a suitable drug for coronavirus patients.”
https://www.jpost.com/health-science/hadassah-doctors-crack-the-cause-of-fatal-corona-blood-clots-631681
@mchill saidThe development of treatments for this virus have been lightning fast compared to most other viruses.
Sounds promising. I'm sure a vaccine or effective treatment will be found one day. I've never seen a virus this difficult to defeat.
For one, I'd say HIV has proven far harder to defeat.